Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas

Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas

Molecular testing using blood-based liquid biopsy approaches has not been widely investigated in patients with glioma. A prospective single-center study enrolled patients with gliomas ranging from grade II to IV. Peripheral blood (PB) was drawn at different timepoints for circulating tumour DNA (ctD...

Full description

Bibliographic Details
Main Authors: Santiago Cabezas-Camarero, Vanesa García-Barberán, Rebeca Pérez-Alfayate, Isabel Casado-Fariñas, Hillary Sloane, Frederick S. Jones, Pedro Pérez-Segura
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
glioma
IDH1
liquid biopsy
circulating tumour DNA
ctDNA
Online Access:https://www.mdpi.com/2072-6694/14/12/2891

Similar Items

Similar Items